Pharmaceutical

Sandoz launches ustekinumab biosimilar in Europe 

Sandoz launched the biosimilar of J&J’s Stelara in Europe in partnership with Samsung Bioepis to treat psoriasis and Crohn’s disease.

Jul 26, 2024 - 04:00
Sandoz launches ustekinumab biosimilar in Europe 
Sandoz launched the biosimilar of J&J’s Stelara in Europe in partnership with Samsung Bioepis to treat psoriasis and Crohn’s disease.
Read the original article

Tags:

Previous Article

Ipsen outlines $461m for ex-US rights to Day One’s glioma therapy

Next Article

ConSynance wins FDA designation for Prader-Willi syndrome therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Current heat warning systems are woefully inadequate in an age of climate change

Opinion: Current heat warning systems are woefully inad...

Apr 11, 2023

Opinion: The window is closing to stop deadly drug-resistant fungi like Candida auris

Opinion: The window is closing to stop deadly drug-resi...

Apr 19, 2023

Talaris Therapeutics to merge with Tourmaline Bio

Talaris Therapeutics to merge with Tourmaline Bio

Jun 23, 2023